Board Meeting Announcement for Kabra Drugs Ltd - May 30, 2025

Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve 1. To consider and approve the audited financial results for the quarter and the year ended on 31st March 2025 pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations 2015; 2. To consider any other matter with the permission of the Chairman of the meeting.